Verition Fund Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$755K Sell
4,000
-67,100
-94% -$14.1M ﹤0.01% 1425
2025
Q4
$14.1M Buy
71,100
+13,900
+24% +$2.81M 0.06% 304
2025
Q3
$11.6M Buy
57,200
+12,400
+28% +$2.2M 0.05% 435
2025
Q2
$7.88M Buy
44,800
+18,000
+67% +$2.71M 0.04% 682
2025
Q1
$3.6M Sell
26,800
-32,000
-54% -$4.21M 0.02% 1103
2024
Q4
$7.42M Buy
58,800
+800
+1% +$119K 0.03% 667
2024
Q3
$9.64M Buy
58,000
+2,100
+4% +$318K 0.05% 420
2024
Q2
$7.44M Buy
55,900
+13,400
+32% +$1.61M 0.04% 498
2024
Q1
$4.47M Buy
+42,500
New +$3.82M 0.03% 751
2022
Q2
Sell
-4,600
Closed -$395K 3024
2022
Q1
$395K Buy
4,600
+400
+10% +$32.9K ﹤0.01% 2034
2021
Q4
$343K Buy
+4,200
New +$307K ﹤0.01% 1918

Other funds holding THC

Verition Fund Management's THC Position: Q1 2026 in Review

Verition Fund Management reduced its Tenet Healthcare (THC) stake by 52% in Q1 2026, selling an estimated $5.72M and leaving 25,466 shares worth $4.81M. The position accounts for 0.03% of the portfolio, ranked #601.

Verition Fund Management first reported a position in THC in Q2 2014 and has held it in 25 quarters since. The position peaked at $10.5M in Q4 2025. 690 funds tracked by Wall St. Rank hold THC as of Q1 2026.

  • Verition Fund Management held 25,466 shares of Tenet Healthcare worth $4.81M as of Q1 2026.
  • Verition Fund Management sold 27,144 Tenet Healthcare shares in Q1 2026, an estimated $5.72M.
  • Tenet Healthcare made up 0.03% of Verition Fund Management's portfolio in Q1 2026, its #601 holding.
  • Verition Fund Management first reported a position in Tenet Healthcare in Q2 2014 and has held it in 25 quarters since.
  • Verition Fund Management's Tenet Healthcare position peaked at $10.5M in Q4 2025.
  • 690 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.